KURA - Kura Oncology Inc. (KURA) CEO Troy Wilson on Q3 2018 Results - Earnings Call Transcript
Kura Oncology, Inc. (KURA)
Q3 2018 Earnings Conference Call
November 5, 2018 4:30 p.m. ET
Executives
Pete De Spain - VP, IR and Corporate Communications
Troy Wilson - President and CEO
Marc Grasso - CFO and Chief Business Officer
Antonio Gualberto - Head, Development and Chief Medical Officer
Analysts
Jonathan Chang - Leerink Partners
Konstantinos Aprilakis - JMP Securities
Joe Pantginis - H.C. Wainwright
Pam Barendt - Cowen & Company
Shawn Egan - Citi
Presentation
Operator
Good day, ladies and gentlemen, and welcome to the Q3 2018 Kura Oncology Earnings Conference Call. At this time,